Saint Bella Group Limited (Saint Bella GP) repurchased 196,000 ordinary shares on 16 September 2026 through on-market transactions on the Hong Kong Stock Exchange.

• Transaction metrics: Purchases were executed between HK$2.90 and HK$3.04 per share, for an aggregate consideration of HK$0.58 million, implying a volume-weighted average price of approximately HK$2.98 per share.

• Impact on share count: The buyback reduced the company’s issued share capital (excluding treasury shares) from 617.26 million to 617.06 million, a decline of 0.03%. Concurrently, treasury shares rose to 5.14 million, while total issued shares remained unchanged at 622.20 million.

• Repurchase mandate utilisation: The transaction forms part of the mandate approved on 30 June 2026, which authorises buybacks of up to 62.22 million shares. To date, 5.14 million shares have been repurchased under this mandate, representing 0.83% of the company’s issued share base on the mandate date.

• Post-repurchase restrictions: In line with Hong Kong listing rules, Saint Bella GP is subject to a moratorium on issuing new shares or disposing of treasury shares until 16 October 2026.

The company confirmed that the repurchase complied with Main Board Rule 10.06 and that no shares repurchased to date have been cancelled, with all 196,000 shares from the latest transaction retained as treasury shares.